Partner with us
To discuss a collaborative discovery and development relationship with Celldex please contact:
Celldex Business Development
(908) 454-7120
rnewbold@
celldextherapeutics.com
Clinical Pipeline
Our broad clinical and preclinical product pipeline covers various cancers, infectious and autoimmune diseases. The figure below illustrates the different stages of development for product candidates in this pipeline.
| Pre-Clinical | Phase I | Phase II | Phase III | |
|---|---|---|---|---|
| Oncology | ||||
| CDX-110 |
 GBM
Ovarian/Prostate
|
|||
| CDX-1307 |
Colon/Bladder/Pancreas
Breast
|
|||
| CDX-1401 |
Solid Tumors
|
|||
| Infectious Disease | ||||
| CDX-2101 |
HBV |
|||
| CDX-2401 |
HIV
|
|||
| Autoimmune Disease | ||||
| CDX-S03 |
Diabetes
|
|||
